12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
During Thursday's pre-market session, several healthcare stocks saw significant movement. OpGen (OPGN), Reshape Lifesciences (RSLS), Atreca (BCEL), Jaguar Health (JAGX), Cardio Diagnostics Hldgs (CDIO), and LogicMark (LGMK) all saw increases, with OpGen leading the pack with a 513.1% increase. On the other hand, Tempest Therapeutics (TPST), Agape ATP (ATPC), Phio Pharma (PHIO), RVL Pharmaceuticals (RVLP), T2 Biosystems (TTOO), and Longeveron (LGVN) all saw decreases, with Tempest Therapeutics leading the losses with a 40.1% decrease.
October 12, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Agape ATP's stock declined by 34.07% during Thursday's pre-market session.
The significant decrease in Agape ATP's stock price is likely to have a negative impact on the company's short-term financial performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Longeveron's stock declined by 17.94% during Thursday's pre-market session.
The significant decrease in Longeveron's stock price is likely to have a negative impact on the company's short-term financial performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Phio Pharma's stock declined by 33.85% during Thursday's pre-market session.
The significant decrease in Phio Pharma's stock price is likely to have a negative impact on the company's short-term financial performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
RVL Pharmaceuticals' shares declined by 31.64% during Thursday's pre-market session.
The significant decrease in RVL Pharmaceuticals' share price is likely to have a negative impact on the company's short-term financial performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Tempest Therapeutics' shares declined by 40.1% during Thursday's pre-market session.
The significant decrease in Tempest Therapeutics' share price is likely to have a negative impact on the company's short-term financial performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
T2 Biosystems' stock decreased by 24.39% during Thursday's pre-market session.
The significant decrease in T2 Biosystems' stock price is likely to have a negative impact on the company's short-term financial performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Atreca's shares rose by 124.57% during Thursday's pre-market session.
The significant increase in Atreca's share price is likely to have a positive impact on the company's short-term financial performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Cardio Diagnostics Hldgs' stock increased by 56.3% during Thursday's pre-market session.
The significant increase in Cardio Diagnostics Hldgs' stock price is likely to have a positive impact on the company's short-term financial performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Jaguar Health's stock moved upwards by 110.74% during Thursday's pre-market session.
The significant increase in Jaguar Health's stock price is likely to have a positive impact on the company's short-term financial performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
LogicMark's shares moved upwards by 34.83% during Thursday's pre-market session.
The significant increase in LogicMark's share price is likely to have a positive impact on the company's short-term financial performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
OpGen's stock increased by 513.1% during Thursday's pre-market session.
The significant increase in OpGen's stock price is likely to have a positive impact on the company's short-term financial performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Reshape Lifesciences' shares increased by 126.44% during Thursday's pre-market session.
The significant increase in Reshape Lifesciences' share price is likely to have a positive impact on the company's short-term financial performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100